Search Congress
Bills
16Honor Our Living Donors Act
Modifies living organ donor reimbursement eligibility by excluding recipient income and requiring review of whether donor expenses are fully covered
Stop Forced Organ Harvesting Act of 2025
Requires sanctions on people and entities involved in forced organ harvesting or organ trafficking, and allows passport denial or revocation for certain organ trafficking offenders
Living Donor Protection Act of 2025
Prohibits insurance carriers from discriminating against living organ donors, protects medical leave during donation recovery, and updates donor education materials
Falun Gong Protection Act
Prohibits involvement in forced organ harvesting tied to Falun Gong practitioners and seeks protections through foreign relations policy
Charlotte Woodward Organ Transplant Discrimination Prevention Act
Prohibits disability-based discrimination in organ transplant access while allowing only individualized medically significant disability assessments and requiring reasonable policy changes
Organ Donation Referral Improvement Act
Requires the Department of Health and Human Services to study hospitals’ use of electronic automated referrals for organ donation and recommend best practices
Charlotte Woodward Organ Transplant Discrimination Prevention Act
Prohibits disability-based discrimination in organ transplant services and organ allocation policies, while requiring accommodations and stronger federal complaint oversight
A resolution authorizing the Sergeant at Arms and Doorkeeper of the Senate to conduct quarterly blood donation drives during the 119th Congress.
Authorize the Sergeant at Arms and Doorkeeper of the Senate to conduct quarterly blood donation drives during the 119th Congress
Falun Gong Protection Act
Requires the President to impose visa and property blocking sanctions on foreign persons involved in involuntary organ harvesting in China, with exceptions for imports and humanitarian transactions
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Extend authorization for stem cell therapeutic and research programs through a 2026 reauthorization measure
Shandra Eisenga Human Cell and Tissue Product Safety Act
Establishes civil penalties and FDA reporting and education requirements for regulation of human cell and tissue products
OPTN Fee Collection Authority Act
Authorize HRSA to collect OPTN transplant waiting list registration fees directly for three years, fund network operations, disclose member fee use, and add oversight of transplant network systems
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Reauthorizes through FY2031 and updates HRSA stem cell transplant programs that match patients with unrelated bone marrow and cord blood donors
The HCT/P Modernization Act of 2025
Require the FDA to educate stakeholders and report to Congress on regulating human cell and tissue products, including Tissue Reference Group guidance and manufacturer oversight data
Mikaela Naylon Give Kids a Chance Act
Expand FDA authority over rare pediatric disease research by strengthening pediatric study enforcement, renewing pediatric incentives and funding, and clarifying orphan drug exclusivity rules
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Funds FY2026 programs and agencies in Labor, Health and Human Services, Education, and related agencies, while setting conditions and restrictions on how appropriated money may be used